Citation Impact
Citing Papers
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Incorporation of sensing modalities into de novo designed fluorescence-activating proteins
2021 StandoutNobel
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
2002
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
2005 StandoutNobel
Beta-2 Adrenergic Activation of L-Type Ca++ Current in Cardiac Myocytes
1997
Dietary supplementation of Vitamin E protects heart tissue from exercise-induced oxidant stress
1992
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Exercise training-induced alterations in skeletal muscle antioxidant capacity: a brief review
1999
Optimization of magnetization transfer experiments for kinetic rate measurements
1994
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Oxidants and Skeletal Muscle Function: Physiologic and Pathophysiologic Implications
1999
The Failing Heart — An Engine Out of Fuel
2007 Standout
Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications
2004
Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases.
1998
Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca2+ release channel
2007 StandoutNobel
Evidence for a β2-Adrenergic/Arachidonic Acid Pathway in Ventricular Cardiomyocytes
1999
Gi Protein-mediated Functional Compartmentalization of Cardiac β2-Adrenergic Signaling
1999
The PDZ Binding Motif of the β1 Adrenergic Receptor Modulates Receptor Trafficking and Signaling in Cardiac Myocytes
2002 StandoutNobel
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
1999 Standout
β2-Adrenergic Receptor-induced p38 MAPK Activation Is Mediated by Protein Kinase A Rather than by Gi or Gβγ in Adult Mouse Cardiomyocytes
2000 StandoutNobel
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Combination therapy with probucol prevents adriamycin-induced cardiomyopathy
1995
GIPC Interacts with the β1-Adrenergic Receptor and Regulates β1-Adrenergic Receptor-mediated ERK Activation
2003 StandoutNobel
Free Radicals, Exercise, and Antioxidant Supplementation
1994
Spontaneous β2-Adrenergic Signaling Fails To Modulate L-Type Ca2+Current in Mouse Ventricular Myocytes
1999
Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene delivery
1999 StandoutNobel
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
2010
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Serum chemistry alterations in Alaskan sled dogs during five successive days of prolonged endurance exercise
2007
Recent advances in the molecular pathophysiology of atrial fibrillation
2011
Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes.
1997 StandoutNobel
The structure and function of G-protein-coupled receptors
2009 StandoutNatureNobel
Gi-Dependent Localization of β2-Adrenergic Receptor Signaling to L-Type Ca2+ Channels
2000
Dexrazoxane in the Prevention of Doxorubicin-Induced Cardiotoxicity
1994
Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance
2009
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Heart???lung interactions
2007
Frequency-encoding Thr17 Phospholamban Phosphorylation Is Independent of Ser16 Phosphorylation in Cardiac Myocytes
2000
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention
2011
Mechanism of Action of Beta-Blocking Agents in Heart Failure
1997
Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery
2008
Caveolar Localization Dictates Physiologic Signaling of β2-Adrenoceptors in Neonatal Cardiac Myocytes
2002 StandoutNobel
Spontaneous Activation of β2- but Not β1-Adrenoceptors Expressed in Cardiac Myocytes from β1β2Double Knockout Mice
2000 StandoutNobel
Use of ICRF-187 for Prevention of Anthracycline Cardiotoxicity in Children: Preliminary Results
1997
Inhibition of Spontaneous β2-Adrenergic Activation Rescues β1-Adrenergic Contractile Response in Cardiomyocytes Overexpressing β2-Adrenoceptor
2000 StandoutNobel
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Protein Kinase A-mediated Phosphorylation of the β2-Adrenergic Receptor Regulates Its Coupling to Gs and Gi
2002 StandoutNobel
Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers
2009
Constitutive β2‐adrenergic signalling enhances sarcoplasmic reticulum Ca2+ cycling to augment contraction in mouse heart
1999
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Cardiac excitation–contraction coupling
2002 StandoutNature
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking
2001 StandoutNobel
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
2007 Standout
The Molecular Basis for Distinct β-Adrenergic Receptor Subtype Actions in Cardiomyocytes
1999
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
β2-Adrenergic cAMP Signaling Is Uncoupled From Phosphorylation of Cytoplasmic Proteins in Canine Heart
1999
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
R-CEPIA1er as a new tool to directly measure sarcoplasmic reticulum [Ca] in ventricular myocytes
2016
Phosphatidylinositol 3-Kinase Functionally Compartmentalizes the Concurrent G s Signaling During β 2 -Adrenergic Stimulation
2002
Analysis of pulsatile, viscous blood flow through diseased coronary arteries of man
1977
Pressure-diameter relationships in the coronary artery of intact, awake calves
1981 StandoutNobel
Rigorous exercise training increases superoxide dismutase activity in ventricular myocardium
1993
Targeting G βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
1999 StandoutNobel
β-Adrenergic Signaling in the Heart: Dual Coupling of the β 2 -Adrenergic Receptor to G s and G i Proteins
2001
Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes
2006 StandoutNobel
Cardiac carbon 13 magnetic resonance spectroscopy: On the horizon or over the rainbow?
2002
Decreased Energy Reserve in an Animal Model of Dilated Cardiomyopathy
1996
Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome
2004 Standout
Coupling of β2-Adrenoceptor to GiProteins and Its Physiological Relevance in Murine Cardiac Myocytes
1999 StandoutNobel
Atrial Fibrillation Increases Production of Superoxide by the Left Atrium and Left Atrial Appendage
2005
Influence of exercise and fiber type on antioxidant enzyme activity in rat skeletal muscle
1994
β-Adrenergic Receptor Blockers Restore Cardiac Calcium Release Channel (Ryanodine Receptor) Structure and Function in Heart Failure
2001
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Recent Advances in Cardiac β2-Adrenergic Signal Transduction
1999
Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial Hypertrophy
1998 StandoutScienceNobel
Stem cell transplantation as a therapy for cardiac fibrosis
2012
Atrial Remodeling and Atrial Fibrillation
2008
Phosphodiesterase 4D is required for β 2 adrenoceptor subtype-specific signaling in cardiac myocytes
2005 StandoutNobel
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
G PROTEIN–COUPLED RECEPTOR KINASES
1998 StandoutNobel
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by β-Adrenergic Receptor Stimulation and Blockade
1998 StandoutNobel
Overexpression of the Cardiac β2-Adrenergic Receptor and Expression of a β-Adrenergic Receptor Kinase-1 (βARK1) Inhibitor Both Increase Myocardial Contractility but Have Differential Effects on Susceptibility to Ischemic Injury
1999 StandoutNobel
Omega-3 Polyunsaturated Fatty Acids Prevent Atrial Fibrillation Associated With Heart Failure but Not Atrial Tachycardia Remodeling
2007
Transgenic Manipulation of Myocardial G Protein–Coupled Receptors and Receptor Kinases
1996 StandoutNobel
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor
2019 StandoutNobel
Spontaneous Activation of β2- but Not β1-Adrenoceptors Expressed in Cardiac Myocytes from β1β2 Double Knockout Mice
2000 StandoutNobel
Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs
2004
The PDZ-binding motif of the β 2 -adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes
2003 StandoutNobel
Charge‐Compensated Metallacarborane Building Blocks for Conjugation with Peptides
2015
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
2000 StandoutNobel
Phospholamban: Protein Structure, Mechanism of Action, and Role in Cardiac Function
1998
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
What Is the Role of β-Adrenergic Signaling in Heart Failure?
2003
Mouse Model of SCN5A -Linked Hereditary Lenegre’s Disease
2005
Works of Robert L. Hamlin being referenced
Transgenic Mice with Cardiac-Specific Expression of Activating Transcription Factor 3, a Stress-Inducible Gene, Have Conduction Abnormalities and Contractile Dysfunction
2001
Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart
2009
Atrial Glutathione Content, Calcium Current, and Contractility
2007
Oxygen cycling in conjunction with stem cell transplantation induces NOS3 expression leading to attenuation of fibrosis and improved cardiac function
2011
n‐3 (omega‐3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling
2006
Dynamic 13C NMR analysis of pyruvate and lactate oxidation in the in vivo canine myocardium: Evidence of reduced utilization with increased work
1997
Alterations in regional blood flow during positive end- expiratory pressure ventilation
1987
Dynamic 13C NMR analysis of oxidative metabolism in the in vivo canine myocardium.
1993
The evolution of -adrenergic dysfunction during the induction of canine cobalt cardiomyopathy
1984
Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs
1985
Hot-Film Anemometer Velocity Measurements of Arterial Blood Flow in Horses
1974 StandoutNobel
Abnormal intrastore calcium signaling in chronic heart failure
2005
Transmural saturation transfer analysis of the creatine kinase system in the mammalian heart
1993
Athletic heart syndrome in dogs competing in a long-distance sled race
1994
Response of Failing Canine and Human Heart Cells to β 2 -Adrenergic Stimulation
1995
Ascorbate Attenuates Atrial Pacing-Induced Peroxynitrite Formation and Electrical Remodeling and Decreases the Incidence of Postoperative Atrial Fibrillation
2001
The efficacy of N-acetylcysteine in preventing doxorubicin-induced cardiomyopathy in dogs.
1983
Effect of pretreatment with ICRF-187 on the total cumulative dose of doxorubicin tolerated by beagle dogs.
1988
Differences in cardioprotective efficacy of adrenergic receptor antagonists and Ca2+ channel antagonists in an animal model of dilated cardiomyopathy. Effects on gross morphology, global cardiac function, and twitch force.
1993
Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin
1985